A BIOPHARMACEUTICAL COMPANY DEVELOPING A DIVERSE PORTFOLIO OF WELL-CHARACTERIZED DRUGS FOR RARE DISEASES

EIGER BIOPHARMACEUTICALS

ABOUT EIGER

MANAGEMENT TEAM

BOARD OF DIRECTORS

SCIENTIFIC ADVISORS

CORPORATE PRESENTATION

EXPANDED ACCESS POLICY

CONTACT US

EIGER PIPELINE

HEALTHCARE CONFERENCE

Cantor Fitzgerald 4th Annual Healthcare Conference Presentation October 1, 2018 4:40 pm EDT New York City

Click for webcast link

RARE DISEASES CAMPAIGN

Eiger campaigns for rare disease research and to raise awareness of the importance of advocating for the rare disease community. The campaign was distributed through USA TODAY on Sept. 14th 2018 and is published online. Click here for the full campaign

NEWS AND EVENTS

PRESS RELEASES

CALENDAR OF EVENTS

HEALTHCARE CONFERENCE

Cantor Fitzgerald 4th Annual Healthcare Conference Presentation October 1, 2018 4:40 pm EDT New York City

Click for webcast link

INVESTOR NEWS & EVENTS

PRESS RELEASES

CALENDAR OF EVENTS

INVESTOR RELATIONS

INVESTOR HOME

STOCK INFORMATION

FINANCIAL INFORMATION

INVESTOR PRESENTATIONS

CORPORATE GOVERNANCE

SHAREHOLDER SERVICES

ANALYST COVERAGE

STOCK PRICE

Prevailing Over HDV

HEPATITIS DELTA (HDV)

ABOUT HDV

ABOUT LONAFARNIB

ABOUT PEGYLATED-INTERFERON-LAMBDA

LONAFARNIB, PEGYLATED-INTERFERON LAMBDA & HDV RESOURCES

LONAFARNIB CLINICAL STUDIES

PEGYLATED-INTERFERON-LAMBDA CLINICAL STUDIES

PUBLICATIONS & PRESENTATIONS

PROFESSIONAL & PATIENT RESOURCES

Rising Above Post-bariatric Hypoglycemia

POST-BARIATRIC HYPOGLYCEMIA

ABOUT POST-BARIATRIC HYPOGLYCEMIA

ABOUT EXENDIN 9-39

GLP-1 RECEPTOR ANTAGONISM

EXENDIN 9-39 & POST-BARIATRIC HYPOGLYCEMIA RESOURCES

EXENDIN 9-39 CLINICAL STUDIES

PUBLICATIONS & PRESENTATIONS

PROFESSIONAL & PATIENT RESOURCES

Conquering Lymphedema

LYMPHEDEMA

ABOUT LYMPHEDEMA

ABOUT UBENIMEX

UBENIMEX & LYMPHEDEMA RESOURCES

UBENIMEX CLINICAL STUDY

PUBLICATIONS AND PRESENTATIONS

PROFESSIONAL AND PATIENT RESOURCES

Overcoming Hutchinson-Gilford Progeria Syndrome

Meet the Kids

HUTCHINSON-GILFORD PROGERIASYNDROME (PROGERIA)

ABOUT HUTCHINSON-GILFORD PROGERIASYNDROME (PROGERIA)

ABOUT LONAFARNIB FOR PROGERIA

EIGER'S PARTNERSHIP WITH THE PROGERIA RESEARCH FOUNDATION (PRF)

LONAFARNIB AND PROGERIA RESOURCES/PUBLICATIONS

LONAFARNIB CLINICAL STUDIES IN PROGERIA

PUBLICATIONS AND PRESENTATIONS

PROFESSIONAL AND PATIENT RESOURCES

Professional and Patient Resources

Post-bariatric Hypoglycemia

Cantor Fitzgerald 4th Annual Healthcare Conference
Presentation October 1, 2018
4:40 pm EDT
New York City

Eiger campaigns for rare disease research and to raise awareness of the importance of advocating for the rare disease community. The campaign was distributed through USA TODAY on Sept. 14th 2018 and is published online.
Click here for the full campaign

Cantor Fitzgerald 4th Annual Healthcare Conference
Presentation October 1, 2018
4:40 pm EDT
New York City

HUTCHINSON-GILFORD PROGERIA
SYNDROME (PROGERIA)

ABOUT HUTCHINSON-GILFORD PROGERIA
SYNDROME (PROGERIA)